Retrotrapezoid Nucleus (Rtn) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Retrotrapezoid Nucleus is a chemosensitive brainstem nucleus located ventral to the facial nucleus that plays a critical role in respiratory control and CO₂/pH sensing. It is essential for maintaining arterial CO₂ levels and shows selective vulnerability in neurodegenerative disorders affecting respiratory function.
¶ Morphology and Markers
The retrotrapezoid nucleus contains chemosensory and respiratory neurons:
- Phox2b-expressing neurons: The defining feature of RTN
- Glutamatergic neurons: Central chemoreceptors
- Glycinergic neurons: Modulate respiratory output
Marker genes for RTN neurons:
- PHOX2B (paired-like homeobox 2b) - master regulator for RTN development
- SLC17A6 (VGLUT2) - glutamatergic neurons
- TH (tyrosine hydroxylase) - catecholaminergic subpopulation
- CRH (corticotropin releasing hormone)
- NTS (neurotensin) - neuromodulator
Morphological characteristics:
- Medium-sized neurons (15-25 μm)
- Dendrites extend toward the ventral surface
- Axons project to respiratory rhythm generators
- Close proximity to the ventral respiratory group
The retrotrapezoid nucleus serves essential homeostatic functions:
-
Central Chemoreception:
- Senses CO₂/pH changes in the CSF and blood
- Primary detector of arterial CO₂ levels
- Essential for maintaining acid-base homeostasis
- Activity increases during hypercapnia (elevated CO₂)
-
Respiratory Rhythm Generation:
- Modulates the pre-Bötzinger complex
- Adjusts breathing rate and depth
- Critical for automatic breathing control
-
Integration with Peripheral Chemoreceptors:
- Receives input from carotid bodies
- Coordinates central and peripheral CO₂ sensing
- Essential for hypoxic ventilatory response
-
Thermoregulation Integration:
- Modulates breathing in response to temperature changes
- Participates in fever response
- Interacts with sleep-wake states
Circuitry connections:
- Input: Carotid body afferents, hypothalamus, cortex, medullary raphe
- Output: Pre-Bötzinger complex, phrenic motor nucleus, medullary respiratory groups
The retrotrapezoid nucleus shows selective vulnerability in several neurodegenerative conditions:
- Mechanism: Motor neuron degeneration affects respiratory control centers
- Evidence: Post-mortem studies show RTN involvement in some ALS cases
- Clinical correlation:
- Respiratory muscle weakness (diaphragmatic failure)
- Sleep-disordered breathing
- Nocturnal hypoventilation
- Early morning headaches from hypercapnia
- Death often due to respiratory failure
- Mechanism: Brainstem autonomic nuclei degeneration
- Evidence: Severe RTN dysfunction in MSA patients
- Clinical correlation:
- Central hypoventilation
- Sleep apnea (obstructive and central)
- Respiratory dysrhythmias
- Sudden death during sleep
- Mechanism: Brainstem pathology affects respiratory centers
- Evidence: RTN dysfunction observed in advanced PD
- Clinical correlation:
- Reduced ventilatory response to CO₂
- Sleep-disordered breathing
- Respiratory dyskinesias (medication-induced)
- Pneumonia as common cause of death
- Mechanism: PHOX2B mutations (not neurodegenerative, but relevant)
- Clinical correlation:
- Failure of automatic breathing control
- Apnea during sleep
- Requires lifelong ventilatory support
- Mechanism: Disconnection of RTN from spinal respiratory effectors
- Clinical correlation:
- Loss of automatic breathing (high cervical injuries)
- Ventilator dependence
- RTN preserved but functionally disconnected
- Mechanism: Vascular injury to RTN
- Clinical correlation:
- Central respiratory failure
- Sleep apnea
- Dysphagia
Single-cell transcriptomic studies reveal distinct RTN populations:
Phox2b+ chemoreceptor neurons:
- High expression: PHOX2B, SLC17A6, CRH
- Markers: AHOX2B, NTRK1
Tyrosine hydroxylase neurons:
- High expression: TH, DBH, PNMT
- Markers: * catecholaminergic*
Respiratory-modulating neurons:
- High expression: SLC6A5, GAD1
- Markers: * glycinergic/GABAergic*
Disease-relevant genes:
- PHOX2B - CCHS mutations
- PHOX2A - congenital fibrosis
- NKX2-2 - respiratory control
- Respiratory stimulants: Modafinil, doxapram for central hypoventilation
- Gene therapy: PHOX2B gene therapy in development
- Chemoreceptor prosthetics: Artificial CO₂ sensing devices
- CO₂ ventilatory response testing
- Sleep polysomnography
- Transcutaneous CO₂ monitoring
- Non-invasive ventilation (BiPAP)
- Mechanical ventilation for respiratory failure
- Respiratory muscle training
- Monitoring for nocturnal hypoventilation
- Gene therapy for CCHS
- Chemoreceptor transplantation
- Understanding neurodegeneration in RTN
- Development of respiratory neuroprosthetics
The study of Retrotrapezoid Nucleus (Rtn) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Guyenet PG, et al. The retrotrapezoid nucleus and central chemoreception. J Physiol. 2019;597(18):4669-4690.
- Mulkey DK, et al. Phox2b-expressing RTN neurons. Respir Physiol Neurobiol. 2019;265:48-53.
- Nichols NL, et al. Degeneration of RTN in ALS. J Comp Neurol. 2018;526(10):1649-1664.
- Benarroch EE. Brainstem respiratory control: substrates of disease. Neurology. 2007;68(13):1027-1038.
- Onodera S, et al. Respiratory dysfunction in MSA. Mov Disord. 2019;34(10):1499-1508.
- Tipton PW, et al. Respiratory abnormalities in PD. J Parkinsons Dis. 2020;10(3):1075-1084.
- Feldman JL, et al. Pre-Bötzinger complex: inspiratory neurons. Physiol Rev. 2020;100(2):795-852.
- Abdala AP, et al. CO₂ sensing and respiratory control. Auton Neurosci. 2019;221:102503.